Navigation Links
Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
Date:4/10/2008

SAN DIEGO, April 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will release its first quarter 2008 financial results on Monday, April 28, 2008 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET. Henry L. Nordhoff, chairman and chief executive officer, and Herm Rosenman, senior vice president, finance, and chief financial officer, will host the call.

The conference call will be webcast live and may be accessed on the investors section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 866-421-6934 (U.S.) or 203-369-0825 (international).

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-K for the year ended December 31, 2007, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904

paulai@gen-probe.com


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
2. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
3. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
4. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
5. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
6. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
7. LeMaitre Vascular Announces Changes to Its Executive Management Team
8. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
9. Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors
10. IHHI Announces Chief Compliance Officer Appointment
11. The Leukemia & Lymphoma Society Announces Appointment of New President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... MELBOURNE, Australia (PRWEB) , ... February 23, 2017 , ... ... . With perseverance and disciplined exercise regime, the author was able to successfully recover. ... Vas-Don collates all relevant information for various sources on the principals of massage, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... in recent years. The technology is so cutting edge, in fact, the U.S. ... for stem cell procedures. However, successful patient outcomes in certain clinical stem cell ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... approach, leads to fewer trips the emergency room, fewer hospital admissions, and better ... Journal of Managed Care® (AJMC®) finds. The study can be found here ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse Expo ... Tom Seay and his production crew. Tom Seay’s program “Best of America by ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... Mass. , Feb. 23, 2017   ... partner to global in vitro diagnostics manufacturers and ... series titled "Catalyzing Implementation of NGS-Based Tests" to ... March 30, 2017 at 11am Eastern Standard Time ... is to highlight the need for improved performance ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: